IDXX Idexx Laboratories Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IDXX

Price (delayed)

$697.98

Market cap

$54.99B

P/E Ratio

46.78

Dividend/share

N/A

EPS

$14.92

Enterprise value

$55.74B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 95

IDEXX Laboratories, Inc., is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We ...

Highlights
The company's equity rose by 20% YoY and by 16% QoQ
The company's EPS rose by 17% YoY and by 4.1% QoQ
IDXX's price to earnings (P/E) is 15% higher than its last 4 quarters average of 41.0 but 2.7% lower than its 5-year quarterly average of 48.4
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.idexx.com
Peers: NEOG WOOF HSIC ABT

Key stats

What are the main financial stats of IDXX

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
-0.66%
1 week
4.07%
1 month
33.22%
1 year
-2.18%
YTD
3.17%
QTD
33.66%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$4.66B
Gross profit
$2.92B
Operating income
$1.51B
Net income
$1.18B
Gross margin
62.7%
Net margin
25.4%
The company's net income rose by 15% YoY and by 3.7% QoQ
IDXX's operating income is up by 15% YoY and by 3.3% from the previous quarter
The gross profit has increased by 14% YoY and by 2.8% QoQ
IDXX's revenue is up by 12% year-on-year and by 2.4% since the previous quarter

Price vs fundamentals

How does IDXX's price correlate with its fundamentals

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
IDXX P/E details
P/E
46.78
P/B
29.42
P/S
11.8
EV/EBIT
36.83
EV/EBITDA
33.35
EV/Sales
11.96
The company's EPS rose by 17% YoY and by 4.1% QoQ
IDXX's price to earnings (P/E) is 15% higher than its last 4 quarters average of 41.0 but 2.7% lower than its 5-year quarterly average of 48.4
The price to book (P/B) is 23% less than the 5-year quarterly average of 38.7 but 8% more than the last 4 quarters average of 27.5
The company's equity rose by 20% YoY and by 16% QoQ
The P/S is 16% above the last 4 quarters average of 10.2 and 8% above the 5-year quarterly average of 11.0
IDXX's revenue is up by 12% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on invested capital has increased by 17% YoY and by 4.1% QoQ
The return on assets rose by 10% year-on-year
Idexx Laboratories's return on equity has increased by 5% YoY
The company's return on sales rose by 3.2% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 102% higher than its total liabilities
The company's total assets rose by 9% YoY and by 8% QoQ
The quick ratio has increased by 3.2% YoY
The debt is 49% less than the equity
IDXX's debt to equity is down by 27% YoY and by 23% QoQ
The company's equity rose by 20% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.